PT  - JOURNAL ARTICLE
AU  - Liu, Di
AU  - Tai, Qidong
AU  - Wang, Yaping
AU  - Pu, Miao
AU  - Ge, Sikai
AU  - Ji, Tingting
AU  - Zhang, Lei
AU  - Su, Bo
TI  - The impact of containment measures and air temperature on mitigating COVID-19 transmission: non-classical SEIR modeling and analysis
AID  - 10.1101/2020.05.12.20099267
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.12.20099267
4099  - http://medrxiv.org/content/early/2020/05/24/2020.05.12.20099267.short
4100  - http://medrxiv.org/content/early/2020/05/24/2020.05.12.20099267.full
AB  - Early non-pharmaceutical interventions (NPIs) are crucial to prevent and control of COVID-19 pandemic. We established a stochastic non-classical SEIR NPIs model (ScEIQRsh) which can quantify the three kinds of NPIs measures simultaneously to mimic the clustered intra-family or intra-acquaintance spreading pattern of COVID-19 under the effective integrated NPIs in Mainland China. Model simulation demonstrated that measures to diminish contactable susceptible (Sc), such as home confinement, travel constraint, social distancing etc. and measures to avoid delay of diagnosis and hospitalized isolation (η) were more effective but consumptive than contact tracing (κ, ρ). From fitted model by MCMC method, the proportion of asymptomatic infectors was 14.88% (IQR 8.17%, 25.37%). The association between air temperature and the fitted transmission rate (β) of COVID-19 suggests that COVID-19 pandemic would be seasonal with the optimal temperature range of 5°C-14°C and peak of 10°C for spreading, and vaccine is indispensable to ultimate prevention COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Shanghai Pulmonary Hospital, Tongji University School of MedicineAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo additional data avaiable.